BI 3810477

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 3810477, covering 2025-06-18 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults [Phase 1]